1.Identify scenarios in which bridging anticoagulation may be appropriate.

2. Identify scenarios in which bridging anticoagulation may be inappropriate.

3.Explain when non-inferiority studies may be useful, and list methodologic considerations when assessing the rigor of a non-inferiority study.


1.Understand that when considering bridging anticoagulation, necessarily assess both risk of thromboembolic event and patient/procedural risks for bleeding.

2. Understand potential options for restricting bridging to those at highest risk

3. Compare and contrast evidence for bridging in atrial fibrillation compared to venous thromboembolic disease

Session date: 
11/28/2016 - 12:00pm to 1:00pm CST
UCMC W-300
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Shannon Martin, MD, MS & Joyce Tang MD. MPH